Merus Labs International (MSL) Stock Price, News & Analysis

Company Overview

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Key Stats

• Today's Range: N/A
• 50-Day Range: C$1.65 to C$1.65
• 52-Week Range: N/A
• Volume: 21,975 shs
• Average Volume: 476,228 shs
• Market Capitalization: C$193.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

MSL Stock Analysis - Frequently Asked Questions

How were Merus Labs International's earnings last quarter?

Merus Labs International Inc. (TSE:MSL) posted its quarterly earnings data on Monday, August, 12th. The specialty pharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.05).

How do I buy shares of Merus Labs International?

Shares of MSL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Merus Labs International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Merus Labs International investors own include Toronto-Dominion Bank (TD), Aurora Cannabis (ACB), (MSLI) (MSLI), NexGen Energy (NXE), ProMetic Life Sciences (PLI), Canopy Growth (CGC) and GuestLogix (GXI).

Company Calendar

• Last Earnings: 8/12/2024
• Today: 11/05/2024
• Next Earnings (Estimated): 11/27/2024

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Finance
• Industry: Major Banks
• Sub-Industry: Banking
• Current Symbol: TSE:MSL
• CUSIP: N/A
• CIK: N/A
• Web: www.meruslabs.com
• Phone: +1-905-7260995
• Fax: N/A
• Employees: 474
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 117,355,000
• Free Float: N/A
• Market Cap: C$193.64 million
• Optionable: Not Optionable
• Beta: N/A